Application of Berberine on Treating Type 2 Diabetes Mellitus

Traditional Chinese medicine (TCM) performs a good clinical practice and is showing a bright future in the treatment of diabetes mellitus (DM). TCM treatment has certain advantages of less toxicity and/or side effects, and herbs could provide multiple therapeutic effects. Berberine (BBR) is a classical natural medicine. In this review, we summarize the application of BBR in the treatment of DM from two aspects. First, modern pharmacological effects of BBR on glucose metabolism are summarized, such as improving insulin resistance, promoting insulin secretion, inhibiting gluconeogenesis in liver, stimulating glycolysis in peripheral tissue cells, modulating gut microbiota, reducing intestinal absorption of glucose, and regulating lipid metabolism. BBR is used to treat diabetic nephropathy (DPN), diabetic neuropathy (DN), and diabetic cardiomyopathy due to its antioxidant and anti-inflammatory activities. Second, the clinical application of BBR is reviewed, such as listing some clinical trials on the effectiveness and safety of BBR, explaining applicable stage and syndrome, the reasonable dose and dose formulation, and the toxicity and/or side effects. This review provides scientific evidence about BBR, as well as introducing some traditional Chinese medical theory and clinical experience, in order to guide clinician to use BBR more suitably and reasonably.

[1]  C. Jin,et al.  Antimicrobial properties of berberines alkaloids in Coptis chinensis Franch by microcalorimetry. , 2008, Journal of biochemical and biophysical methods.

[2]  J Auwerx,et al.  The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. , 1996, Biochimica et biophysica acta.

[3]  Wei-Jia Kong,et al.  Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. , 2010, Metabolism: clinical and experimental.

[4]  Jian-Dong Jiang,et al.  Antioxidant and Anti-Inflammatory Activities of Berberine in the Treatment of Diabetes Mellitus , 2014, Evidence-based complementary and alternative medicine : eCAM.

[5]  F. Lu,et al.  Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis , 2012, Evidence-based complementary and alternative medicine : eCAM.

[6]  Jianping Ye,et al.  Efficacy of berberine in patients with type 2 diabetes mellitus. , 2008, Metabolism: clinical and experimental.

[7]  W. Xie,et al.  Effects and Action Mechanisms of Berberine and Rhizoma coptidis on Gut Microbes and Obesity in High-Fat Diet-Fed C57BL/6J Mice , 2011, PloS one.

[8]  J. Grzywacz,et al.  Complementary and alternative medicine use among adults with diabetes in the United States. , 2006, Alternative therapies in health and medicine.

[9]  D. James,et al.  Berberine and Its More Biologically Available Derivative, Dihydroberberine, Inhibit Mitochondrial Respiratory Complex I , 2008, Diabetes.

[10]  Patrice D Cani,et al.  The role of the gut microbiota in energy metabolism and metabolic disease. , 2009, Current pharmaceutical design.

[11]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[12]  Myeong Soo Lee,et al.  Survey of the use of complementary and alternative medicine among Korean diabetes mellitus patients , 2004, Pharmacoepidemiology and drug safety.

[13]  C. Beaurepaire,et al.  Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats. , 2011, Metabolism: clinical and experimental.

[14]  M. Crowell,et al.  Gut microbiota and its possible relationship with obesity. , 2008, Mayo Clinic proceedings.

[15]  A Furnham,et al.  Why do patients turn to complementary medicine? An empirical study. , 1996, The British journal of clinical psychology.

[16]  G. Derosa,et al.  Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials , 2012, Expert opinion on biological therapy.

[17]  Bao-lin Liu,et al.  Berberine Inhibits Inflammatory Response and Ameliorates Insulin Resistance in Hepatocytes , 2011, Inflammation.

[18]  Langchong He,et al.  Synthesis and antihyperglycemic evaluation of various protoberberine derivatives. , 2006, Bioorganic & medicinal chemistry letters.

[19]  Wei-Jia Kong,et al.  Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. , 2009, Metabolism: clinical and experimental.

[20]  Shousi Lu,et al.  Berberine attenuates intestinal disaccharidases in streptozotocin-induced diabetic rats. , 2008, Die Pharmazie.

[21]  Hyun-Joung Lim,et al.  Berberine-induced LDLR up-regulation involves JNK pathway. , 2007, Biochemical and biophysical research communications.

[22]  P. Chowienczyk,et al.  Chronic Inflammatory Disorders and Risk of Type 2 Diabetes Mellitus, Coronary Heart Disease, and Stroke: A Population-Based Cohort Study , 2014, Circulation.

[23]  Jiyin Zhou,et al.  Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver. , 2011, Fitoterapia.

[24]  T. Tzeng,et al.  The Selected Traditional Chinese Medicinal Formulas for Treating Diabetic Nephropathy: Perspective of Modern Science , 2013, Journal of traditional and complementary medicine.

[25]  M. Hanefeld,et al.  Hypoglykämie und Herzrhythmusstörungen bei Patienten mit Diabetes Typ 2 , 2014, Herz.

[26]  Xiao-dong Liu,et al.  Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study , 2010, Naunyn-Schmiedeberg's Archives of Pharmacology.

[27]  K. Gupta,et al.  O-Hexadecyl-Dextran Entrapped Berberine Nanoparticles Abrogate High Glucose Stress Induced Apoptosis in Primary Rat Hepatocytes , 2014, PloS one.

[28]  Shufeng Zhou,et al.  Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose. , 2008, Archives of biochemistry and biophysics.

[29]  P. Bhutada,et al.  Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes , 2011, Behavioural Brain Research.

[30]  Linhua Zhao,et al.  Syndrome Differentiation of Diabetes by the Traditional Chinese Medicine according to Evidence-Based Medicine and Expert Consensus Opinion , 2014, Evidence-based complementary and alternative medicine : eCAM.

[31]  N. de Kimpe,et al.  Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. , 2004, Journal of ethnopharmacology.

[32]  P. R. Vuddanda,et al.  Berberine: a potential phytochemical with multispectrum therapeutic activities , 2010, Expert opinion on investigational drugs.

[33]  Junling Han,et al.  Modulating gut microbiota as an anti-diabetic mechanism of berberine , 2011, Medical science monitor : international medical journal of experimental and clinical research.

[34]  F. Lu,et al.  Facilitating effects of berberine on rat pancreatic islets through modulating hepatic nuclear factor 4 alpha expression and glucokinase activity. , 2008, World journal of gastroenterology.

[35]  C. Nakamura,et al.  In vitro antifungal activity of the berberine and its synergism with fluconazole , 2010, Antonie van Leeuwenhoek.

[36]  Weihua Liu,et al.  Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase. , 2008, Chinese medical journal.

[37]  M. Doble,et al.  Mechanism of action of natural products used in the treatment of diabetes mellitus , 2011, Chinese journal of integrative medicine.

[38]  Jin-Yuarn Lin,et al.  Berberine, an isoquinoline alkaloid in herbal plants, protects pancreatic islets and serum lipids in nonobese diabetic mice. , 2011, Journal of agricultural and food chemistry.

[39]  M. Kheir,et al.  Acute toxicity of berberine and its correlation with the blood concentration in mice. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[40]  Yan Wang,et al.  Berberine Improves Insulin Sensitivity by Inhibiting Fat Store and Adjusting Adipokines Profile in Human Preadipocytes and Metabolic Syndrome Patients , 2012, Evidence-based complementary and alternative medicine : eCAM.

[41]  Wei Zhang,et al.  Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus. , 2008, Chinese medical journal.

[42]  Suphia M Sherbeeni,et al.  Pharmacological management of type 2 diabetes mellitus: an update. , 2011, Current diabetes reviews.

[43]  Yuebo Zhang,et al.  Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway , 2006 .

[44]  J. Berger,et al.  The mechanisms of action of PPARs. , 2002, Annual review of medicine.

[45]  J. Brusq,et al.  Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine Published, JLR Papers in Press, February 28, 2006. , 2006, Journal of Lipid Research.

[46]  Jin-Yuarn Lin,et al.  Protective effect of berberine on serum glucose levels in non-obese diabetic mice. , 2012, International immunopharmacology.

[47]  Jingwen Liu,et al.  Extracellular Signal-Regulated Kinase–Dependent Stabilization of Hepatic Low-Density Lipoprotein Receptor mRNA by Herbal Medicine Berberine , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[48]  J. B. Kim,et al.  Berberine suppresses proinflammatory responses through AMPK activation in macrophages. , 2009, American journal of physiology. Endocrinology and metabolism.

[49]  Guangji Wang,et al.  Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats. , 2008, The Journal of endocrinology.

[50]  Wei-Jia Kong,et al.  Human low-density lipoprotein receptor gene and its regulation , 2005, Journal of Molecular Medicine.

[51]  P. Kakkar,et al.  Antihyperglycemic and antioxidant effect of Berberis aristata root extract and its role in regulating carbohydrate metabolism in diabetic rats. , 2009, Journal of ethnopharmacology.

[52]  Jianping Ye,et al.  Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis , 2011, PloS one.

[53]  S. Pund,et al.  Improvement of anti-inflammatory and anti-angiogenic activity of berberine by novel rapid dissolving nanoemulsifying technique. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[54]  W. Xie,et al.  Traditional Chinese Medicines in Treatment of Patients with Type 2 Diabetes Mellitus , 2011, Evidence-based complementary and alternative medicine : eCAM.

[55]  D. James,et al.  Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States , 2006, Diabetes.

[56]  M. Li,et al.  Structural Changes of Gut Microbiota during Berberine-Mediated Prevention of Obesity and Insulin Resistance in High-Fat Diet-Fed Rats , 2012, PloS one.

[57]  M. Gu,et al.  Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK. , 2006, Biochimica et biophysica acta.

[58]  J. Nagpal,et al.  Quality of Diabetes Care in the Middle- and High-Income Group Populace , 2006, Diabetes Care.

[59]  Zhijun Wang,et al.  Treating Type 2 Diabetes Mellitus with Traditional Chinese and Indian Medicinal Herbs , 2013, Evidence-based complementary and alternative medicine : eCAM.

[60]  Suowen Xu,et al.  Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: Involvement of NF-κB signaling pathway , 2011, Molecular and Cellular Endocrinology.

[61]  Wei Wei,et al.  Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. , 2006, Journal of ethnopharmacology.

[62]  Yuebo Zhang,et al.  Berberine inhibits PTP1B activity and mimics insulin action. , 2010, Biochemical and biophysical research communications.

[63]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[64]  Suowen Xu,et al.  Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK-S1P signaling pathway. , 2010, Archives of biochemistry and biophysics.

[65]  P. Turnbaugh,et al.  Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.

[66]  V. Torchilin.  Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery , 2014, Nature Reviews Drug Discovery.

[67]  C. Xie,et al.  Fructus Mume Formula in the Treatment of Type 2 Diabetes Mellitus: A Randomized Controlled Pilot Trial , 2013, Evidence-based complementary and alternative medicine : eCAM.

[68]  Le Zhang,et al.  Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats. , 2008, Biological & pharmaceutical bulletin.

[69]  Ying Wang.  Attenuation of berberine on lipopolysaccharide-induced inflammatory and apoptosis responses in β-cells via TLR4-independent JNK/NF-κB pathway , 2014, Pharmaceutical biology.

[70]  G. Ning,et al.  Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. , 2008, The Journal of clinical endocrinology and metabolism.

[71]  C. Hyun,et al.  Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes. , 2007, Biological & pharmaceutical bulletin.

[72]  Guangji Wang,et al.  Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies. , 2010, Biochemical pharmacology.

[73]  A. Agarwal,et al.  Prescribing pattern and efficacy of anti-diabetic drugs in maintaining optimal glycemic levels in diabetic patients , 2014, Journal of basic and clinical pharmacy.

[74]  Xinhua Xiao,et al.  Berberine Moderates Glucose and Lipid Metabolism through Multipathway Mechanism , 2010, Evidence-based complementary and alternative medicine : eCAM.

[75]  Jin-Taek Hwang,et al.  AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols. , 2009, New biotechnology.

[76]  I. Singh,et al.  Berberine and its derivatives: a patent review (2009 – 2012) , 2013, Expert opinion on therapeutic patents.

[77]  Jianping Ye,et al.  Berberine improves glucose metabolism through induction of glycolysis. , 2008, American journal of physiology. Endocrinology and metabolism.

[78]  E. Asante.  Interventions to promote treatment adherence in type 2 diabetes mellitus. , 2013, British journal of community nursing.

[79]  M. Gu,et al.  8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models. , 2010, Bioorganic & medicinal chemistry.

[80]  Satoru Inaba,et al.  Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins , 2004, Nature Medicine.

[81]  W. Jia,et al.  [Study on effects of baicalin, berberine and Astragalus polysaccharides and their combinative effects on aldose reductase in vitro]. , 2009, Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials.

[82]  F. Lu,et al.  The Effects of Berberine on Blood Lipids: A Systemic Review and Meta-Analysis of Randomized Controlled Trials , 2013, Planta Medica.

[83]  W. Xie,et al.  Diabetes is an inflammatory disease: evidence from traditional Chinese medicines , 2011, Diabetes, obesity & metabolism.

[84]  Jianping Ye,et al.  Traditional chinese medicine in treatment of metabolic syndrome. , 2008, Endocrine, metabolic & immune disorders drug targets.

[85]  D. Hardie,et al.  AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. , 2005, Cell metabolism.

[86]  Chen Qm,et al.  [Studies on the hypoglycemic effect of Coptis chinensis and berberine]. , 1986, Yao xue xue bao = Acta pharmaceutica Sinica.

[87]  L. Ding,et al.  Determination of berberine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry. , 2007, Journal of pharmaceutical and biomedical analysis.

[88]  Yang Yang,et al.  Identification of the toxic constituents in Rhizoma Coptidis. , 2010, Journal of ethnopharmacology.

[89]  I. Laher,et al.  Antioxidant therapy in human endocrine disorders. , 2009, Medical science monitor : international medical journal of experimental and clinical research.